Long-term effects of radiotherapy in head and neck cancer: Trismus and patient perspectives
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This thesis aims to increase knowledge about patients’ long-term symptoms related to
mouth opening, pain perception, and health-related quality of life (HRQL) after
radiotherapy for head and neck cancer (HNC). Furthermore, it aims to enhance the
understanding of how patients experience and cope with troublesome symptoms and
how healthcare can improve support for this patient group. Papers I–III, longitudinal
cohort studies of patients with HNC in Region Västra Götaland, Sweden, assess
maximal interincisal opening (MIO) and HRQL using validated questionnaires for up
to five years post-treatment. Paper IV explores postradiation trismus by analyzing
interviews using qualitative content analysis.
Results: Paper I: Prevalence of trismus was 27% at the 1-year follow-up and 28% at the
5-year follow-up. Paper II: Patients with trismus reported significantly poorer HRQL
and a higher symptom burden related to mouth opening at both the 1-year and 5-year
follow-ups compared to those without trismus. Paper III: Facial pain was reported by
50% of the cohort before oncologic treatment, 70% at the 3-month follow-up, 54% at
the 1-year follow-up, and 41% at the 5-year follow-up. Patients reporting pain had
significantly smaller MIO and scored worse on more HRQL items. Paper IV: Four main
categories were identified: Bodily symptoms, Effects on life, Support from the
healthcare system, and Strategies to handle life and symptoms. Difficulties with
eating and limited social function were commonly reported. Patients wanted healthcare
providers to provide more information about access to support groups and counseling.
Conclusions: Trismus and facial pain are common, long-lasting complications
following radiotherapy for HNC that impact HRQL. A multidisciplinary team approach
and individualized follow-up with evidence-based care would support long-term
wellbeing in this patient group.